Use of induced pluripotent stem cells to define genetic factors involved in abnormal myeloproliferation and leukaemia in Down syndrome patients (2011-2014)

Professor Ernst Wolvetang

Senior Group Leader

Australian Institute for Bioengineering and Nanotechnology